AgomAb Therapeutics NV (AGMB) insider trading
Every open-market stock purchase and sale by AgomAb Therapeutics NV executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- David R Epstein (Director) and 2 others bought $400K in the last 90 days, more than doubling their stake.
Last 12 months: insiders bought $400K (5 buys) and sold $0 (0 sales). Last close $9.26 on Oct 22, 2026.
Recent AGMB insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 21, 2026 | David R Epstein (Director) | Bought | $44.5K |
| Oct 21, 2026 | David R Epstein (Director) | Bought | $44.3K |
| Oct 8, 2026 | David R Epstein (Director) | Bought | $44.5K |
| Oct 6, 2026 | Tim Jasper Knotnerus (CEO) | Bought | $43.5K |
| Oct 6, 2026 | David R Epstein (Director) | Bought | $43.5K |
| Oct 6, 2026 | Pierre Thadee Victor Kemula (CFO) | Bought | $42.9K |
| Oct 6, 2026 | Pierre Thadee Victor Kemula (CFO) | Bought | $26K |
| Oct 6, 2026 | Pierre Thadee Victor Kemula (CFO) | Bought | $17.1K |
| Oct 5, 2026 | Tim Jasper Knotnerus (CEO) | Bought | $50.9K |
| Oct 5, 2026 | David R Epstein (Director) | Bought | $42.9K |
| Sep 11, 2026 | Marino Garcia (Director) | Bought (not open market) | — |
| Sep 11, 2026 | Naimish Patel (Director) | Bought (not open market) | — |
Who's trading AGMB
- David R Epstein, Director: bought $220K (5 buys), last Oct 21, 2026
- Pierre Thadee Victor Kemula, CFO: bought $85.9K (3 buys), last Oct 6, 2026
- Tim Jasper Knotnerus, CEO: bought $94.4K (2 buys), last Oct 6, 2026
- Marino Garcia, Director: other filings, last Sep 11, 2026
- Naimish Patel, Director: other filings, last Sep 11, 2026
Get free alerts when an insider at AgomAb Therapeutics NV files a new trade →